Stay updated on OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A site-wide banner announces NIH website transition updates and says the agency is using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-24T12:29:21.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The site footer’s revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T12:54:15.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1, while the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T13:15:17.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error for the study record NCT04505826, replacing the previous content visible to users. This indicates an access restriction or server-side issue that prevents loading the study details.
    Difference
    18%
    Check dated 2026-09-19T18:26:43.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Revision changed from v3.6.5 to v3.6.6, indicating a new release of the page’s content. This update signals administrative or formatting improvements and does not modify the study details.
    Difference
    0.1%
    Check dated 2026-08-29T19:28:37.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The revision label on the page updated from v3.6.4 to v3.6.5, indicating a small platform update rather than a substantive content change.
    Difference
    0.0%
    Check dated 2026-08-08T23:24:39.000Z thumbnail image

Stay in the know with updates to OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial page.